Jpmorgan Chase & CO Evolent Health, Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Evolent Health, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 4,354,740 shares of EVH stock, worth $102 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,354,740
Previous 4,747,107
8.27%
Holding current value
$102 Million
Previous $156 Million
46.51%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding EVH
# of Institutions
271Shares Held
124MCall Options Held
519KPut Options Held
1.2M-
Wellington Management Group LLP Boston, MA11.2MShares$261 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$258 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.69MShares$203 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.51MShares$199 Million2.45% of portfolio
-
William Blair Investment Management, LLC Chicago, IL5.03MShares$117 Million0.26% of portfolio
About Evolent Health, Inc.
- Ticker EVH
- Exchange NYSE
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 97,063,696
- Market Cap $2.27B
- Description
- Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical pl...